Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Miguel Pedro de Queiroz Neto
Institution:
Hospital Nossa Senhora das Graças
Observed institutions:
Hospital Nossa Senhora das Graças,
Hospital de Clínicas Universidade Federal do Paraná,
Universidade Federal do Paraná
ORCID:
0000-0001-9894-3063
Observed ORCID:
0000-0001-9894-3063
OpenAlex ID:
A5035598106
Survival benefit of pediatric-based regimen for adults with acute lymphoblastic leukemia: A single-center retrospective cohort
2021
·
Miguel Pedro de Queiroz Neto
, Larissa da Costa
, et al.
·
Hematology Transfusion and Cell Therapy
·
5
PDF
Idiopathic hypereosinophilic syndrome with 20 years of diagnostic delay
2017
·
Miguel Pedro de Queiroz Neto
, Fernando Antônio Galvão Gondim Filho
·
Revista Brasileira de Hematologia e Hemoterapia
·
4
PDF
Low Rates of Documented Infection in Patients with Acute Myeloid Leukemia (AML) Receiving Venetoclax + Hypomethylating Agents (VEN-HMA)
2024
·
Abel Costa Neto
, Renata Lyrio R Baptista
, et al.
·
Blood
·
1
Fungemia Por Kodamaea Ohmeri Em Imunossuprimido: Um Relato De Caso
2023
·
Nubia Leilane Barth Schierling
, Fernanda Pereira Pedroso
, et al.
·
The Brazilian Journal of Infectious Diseases
·
1
POSTER: AML-631 Clinical Characteristics, Infectious Complications, and Outcomes of Patients Treated With Venetoclax Plus Hypomethylating Agents (VEN-HMA)
2025
·
Mariana Guaraná
, Abel Costa
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
AML-631: Clinical Characteristics, Infectious Complications, and Outcomes of Patients Treated With Venetoclax Plus Hypomethylating Agents (VEN-HMA)
2025
·
Mariana Guaraná
, Abel Costa
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
6
Citation count:
11
H-index:
2
I10-index:
Year
Topic
Type
